Table 1 Patient-, tumor-, and treatment-related characteristics
All Patients (n = 44,498) | Immunotherapy (n = 5807) | Chemotherapy (n = 38,691) | p-value | |||||
|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | |||
Sex | Male | 24,693 | 55.5 | 3031 | 52.2 | 21,662 | 56.0 | < 0.001 |
Female | 19,805 | 44.5 | 2776 | 47.8 | 17,029 | 44.0 | ||
Age | 18–59 | 13,849 | 31.1 | 1947 | 33.5 | 11,902 | 30.8 | < 0.001 |
60–69 | 15,487 | 34.8 | 2060 | 35.5 | 13,427 | 34.7 | ||
70–79 | 12,224 | 27.5 | 1499 | 25.8 | 10,725 | 27.7 | ||
80+ | 2938 | 6.6 | 301 | 5.2 | 2637 | 6.8 | ||
Comorbidity | 0 | 28,932 | 65.0 | 3889 | 67.0 | 25,043 | 64.7 | < 0.001 |
1 | 11,280 | 25.3 | 1456 | 25.1 | 9824 | 25.4 | ||
> 2 | 4286 | 9.6 | 462 | 8.0 | 3824 | 9.9 | ||
Histology | Adenocarcinoma | 26,202 | 58.9 | 4596 | 79.1 | 21,606 | 55.8 | < 0.001 |
Non-adenocarcinoma | 18,296 | 41.1 | 1211 | 20.9 | 17,085 | 44.2 | ||
Race | White | 37,293 | 83.8 | 4950 | 85.2 | 32,343 | 83.6 | < 0.001 |
Non-white | 7205 | 16.2 | 857 | 14.8 | 6348 | 16.4 | ||
Insurance | Uninsured | 1871 | 4.2 | 186 | 3.2 | 1685 | 4.4 | < 0.001 |
Insured | 42,627 | 95.8 | 5621 | 96.8 | 37,006 | 95.6 | ||
Facility Type | Academic | 14,480 | 32.5 | 1913 | 32.9 | 12,567 | 32.5 | 0.48 |
Nonacademic | 30,018 | 67.5 | 3894 | 67.1 | 26,124 | 67.5 | ||
Radiation | No Radiation | 21,593 | 48.5 | 3344 | 57.6 | 18,249 | 47.2 | < 0.001 |
EBRT | 20,821 | 46.8 | 2235 | 38.5 | 18,586 | 48.0 | ||
SRT | 2084 | 4.7 | 228 | 3.9 | 1856 | 4.8 | ||
Systemic Agent | Multi-agent chemotherapy | 38,691 | 86.9 | |||||
Immunotherapy | 5807 | 13.1 | ||||||